Gene annotation and drug target discovery in candida albicans with a tagged transposon mutant collection

PLoS Pathogens

Volumn 6, Issue 10, 2010, Pages

  Oh, Julia ^a,b   Fung, Eula ^b   Schlecht, Ulrich ^b   Davis, Ronald W ^a,b   Giaever, Guri ^c,d,e   Onge, Robert P St ^b   Deutschbauer, Adam ^f   Nislow, Corey ^d,e  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Donnelley Center for Cellular and Biomolecular Research   (Canada)

^f LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGUS GROWTH; GENE IDENTIFICATION; GENETIC SCREENING; NONHUMAN; SACCHAROMYCES CEREVISIAE; TRANSPOSON;

CANDIDA ALBICANS; DNA TRANSPOSABLE ELEMENTS; DRUG DISCOVERY; FOOD; GENE EXPRESSION PROFILING; GENOMIC LIBRARY; HAPLOINSUFFICIENCY; MICROARRAY ANALYSIS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR TARGETED THERAPY; MUTAGENESIS, INSERTIONAL; ORGANISMS, GENETICALLY MODIFIED; SEQUENCE TAGGED SITES;

CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 78449258550     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001140     Document Type: Article

References (62)

1. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon- Regidor MA, et al. (1997) Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23: 23-30.
2. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-317.
4. Akins RA (2005) An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43: 285-318.
5. Heckman DS, Geiser DM, Eidell BR, Stauffer RL, Kardos NL, et al. (2001) Molecular Evidence for the Early Colonization of Land by Fungi and Plants. Science 293: 1129-1133.
6. Lott TJ, Fundyga RE, Kuykendall RJ, Arnold J (2005) The human commensal yeast, Candida albicans, has an ancient origin. Fungal Genetics and Biology 42: 444-451.
7. McCusker JH, Clemons KV, Stevens DA, Davis RW (1994) Genetic characterization of pathogenic Saccharomyces cerevisiae isolates. Genetics 136: 1261-1269.
8. Bennett RJ, Johnson AD (2003) Completion of a parasexual cycle in Candida albicans by induced chromosome loss in tetraploid strains. EMBO J 22: 2505-2515.
9. O'Brien KP, Remm M, Sonnhammer EL (2005) Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res 33: D476-480.
10. Skrzypek MS, Arnaud MB, Costanzo MC, Inglis DO, Shah P, et al. (2010) New tools at the Candida Genome Database: biochemical pathways and full-text literature search. Nucl Acids Res 38: D428-432.
11. Costanzo M, Giaever G, Nislow C, Andrews B (2006) Experimental approaches to identify genetic networks. Curr Opin Biotechnol 17: 472-480.
12. Hoon S, St Onge RP, Giaever G, Nislow C (2008) Yeast chemical genomics and drug discovery: an update. Trends Pharmacol Sci 29: 499-504.
13. Shoemaker DD, Lashkari DA, Morris D, Mittmann M, Davis RW (1996) Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat Genet 14: 450-456.
14. Giaever G, Chu AM, Ni L, Connelly C, Riles L, et al. (2002) Functional profiling of the Saccharomyces cerevisiae genome. Nature 418: 387-391.
15. Smith AM, Heisler LE, Mellor J, Kaper F, Thompson MJ, et al. (2009) Quantitative phenotyping via deep barcode sequencing. Genome Res.
16. Ooi SL, Shoemaker DD, Boeke JD (2003) DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray. Nat Genet 35: 277-286.
17. Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, et al. (2004) Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A 101: 793-798.
18. Hillenmeyer ME, Fung E, Wildenhain J, Pierce SE, Hoon S, et al. (2008) The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320: 362-365.
19. Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, et al. (2004) Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116: 121-137.
20. Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, et al. (2006) Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126: 611-625.
21. Davis DA, Bruno VM, Loza L, Filler SG, Mitchell AP (2002) Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162: 1573-1581.
22. Uhl MA, Biery M, Craig N, Johnson AD (2003) Haploinsufficiency-based largescale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans. EMBO J 22: 2668-2678.
23. Xu D, Jiang B, Ketela T, Lemieux S, Veillette K, et al. (2007) Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog 3: e92.
24. Jiang B, Xu D, Allocco J, Parish C, Davison J, et al. (2008) PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem Biol 15: 363-374.
25. Rodriguez-Suarez R, Xu D, Veillette K, Davison J, Sillaots S, et al. (2007) Mechanism-of-action determination of GMP synthase inhibitors and target validation in Candida albicans and Aspergillus fumigatus. Chem Biol 14: 1163-1175.
26. Xu D, Sillaots S, Davison J, Hu W, Jiang B, et al. (2009) Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans. J Biol Chem 284: 19754-19764.
27. Oh J, Fung E, Price MN, Dehal PS, Davis RW, et al. (2010) A universal TagModule collection for parallel genetic analysis of microorganisms. Nucleic Acids Res 38: e146.
28. Enloe B, Diamond A, Mitchell AP (2000) A single-transformation gene function test in diploid Candida albicans. J Bacteriol 182: 5730-5736.
29. Deutschbauer AM, Jaramillo DF, Proctor M, Kumm J, Hillenmeyer ME, et al. (2005) Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics 169: 1915-1925.
30. Hengartner CJ, Thompson CM, Zhang J, Chao DM, Liao SM, et al. (1995) Association of an activator with an RNA polymerase II holoenzyme. Genes Dev 9: 897-910.
31. Itoh R, Saint-Marc C, Chaignepain S, Katahira R, Schmitter JM, et al. (2003) The yeast ISN1 (YOR155c) gene encodes a new type of IMP-specific 59- nucleotidase. BMC Biochem 4: 4.
32. Pan X, Yuan DS, Xiang D, Wang X, Sookhai-Mahadeo S, et al. (2004) A robust toolkit for functional profiling of the yeast genome. Mol Cell 16: 487-496.
33. Roemer T, Jiang B, Davison J, Ketela T, Veillette K, et al. (2003) Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 50: 167-181.
34. Lee W, St Onge RP, Proctor M, Flaherty P, Jordan MI, et al. (2005) Genomewide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet 1: e24.
35. Huh WK, Kang SO (2001) Characterization of the gene family encoding alternative oxidase from Candida albicans. Biochem J 356: 595-604.
36. Elson SL, Noble SM, Solis NV, Filler SG, Johnson AD (2009) An RNA Transport System in Candida albicans Regulates Hyphal Morphology and Invasive Growth. PLoS Genet 5: e1000664.
37. Zaragoza O, Rodriguez C, Gancedo C (2000) Isolation of the MIG1 gene from Candida albicans and effects of its disruption on catabolite repression. J Bacteriol 182: 320-326.
38. Menon V, Bernardis FD, Calderone R, Chauhan N (2008) Transcriptional profiling of the Candida albicans Ssk1p receiver domain point mutants and their virulence. FEMS Yeast Research 8: 756-763.
39. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, et al. (2004) Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell 3: 536-545.
40. Giaever G, Shoemaker DD, Jones TW, Liang H, Winzeler EA, et al. (1999) Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21: 278-283.
41. Nicholls DG, Ferguson SJ (2001) A standard and up-to-date textbook with a comprehensive introduction to membrane bioenergetics and the chemiosmotic theory. Bioenergetics 3: 17-26.
42. Peyroche A, Antonny B, Robineau S, Acker J, Cherfils J, et al. (1999) Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: involvement of specific residues of the Sec7 domain. Mol Cell 3: 275-285.
43. Lewis MJ, Pelham HRB (2002) A New Yeast Endosomal SNARE Related to Mammalian Syntaxin 8. Traffic 3: 922-929.
44. Wapinski I, Pfeffer A, Friedman N, Regev A (2007) Natural history and evolutionary principles of gene duplication in fungi. Nature 449: 54-61.
45. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, et al. (2010) The genetic landscape of a cell. Science 327: 425-431.
46. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, et al. (1999) Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285: 901-906.
47. Vazquez N, Walsh TJ, Friedman D, Chanock SJ, Lyman CA (1998) Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect Immun 66: 145-150.
48. Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, et al. (2004) The diploid genome sequence of Candida albicans. Proc Natl Acad Sci U S A 101: 7329-7334.
49. Holmes AR, Tsao S, Ong SW, Lamping E, Niimi K, et al. (2006) Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2. Mol Microbiol 62: 170-186.
50. Padovan ACB, Chaves GM, Colombo AL, Briones MRS (2009) A novel allele of HWPI, isolated from a clinical strain of Candida albicans with defective hyphal growth and biofilm formation, has deletions of Gln/Pro and Ser/Thr repeats involved in cellular adhesion. Medical Mycology 47: 824-835.
51. Gimeno CJ, Ljungdahl PO, Styles CA, Fink GR (1992) Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: Regulation by starvation and RAS. Cell 68: 1077-1090.
52. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
53. Forgac M (1999) Structure and properties of the vacuolar (H+)-ATPases. J Biol Chem 274: 12951-12954.
54. Goryshin IY, Jendrisak J, Hoffman LM, Meis R, Reznikoff WS (2000) Insertional transposon mutagenesis by electroporation of released Tn5 transposition complexes. Nat Biotechnol 18: 97-100.
55. Wilson RB, Davis D, Mitchell AP (1999) Rapid Hypothesis Testing with Candida albicans through Gene Disruption with Short Homology Regions. J Bacteriol 181: 1868-1874.
56. Kadosh D, Johnson AD (2001) Rfg1, a protein related to the Saccharomyces cerevisiae hypoxic regulator Rox1, controls filamentous growth and virulence in Candida albicans. Mol Cell Biol 21: 2496-2505.
57. Pierce SE, Davis RW, Nislow C, Giaever G (2007) Genome-wide analysis of barcoded Saccharomyces cerevisiae gene-deletion mutants in pooled cultures. Nat Protoc 2: 2958-2974.
58. Chauhan N, Kruppa MD (2009) Standard growth media and common techniques for use with Candida albicans. Methods Mol Biol 499: 197-201.
59. Pierce SE, Fung EL, Jaramillo DF, Chu AM, Davis RW, et al. (2006) A unique and universal molecular barcode array. Nat Methods 3: 601-603.
60. Alberti S, Gitler AD, Lindquist S (2007) A suite of Gateway cloning vectors for high-throughput genetic analysis in Saccharomyces cerevisiae. Yeast 24: 913-919.
61. Ho CH, Magtanong L, Barker SL, Gresham D, Nishimura S, et al. (2009) A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 27: 369-377.
62. Hoon S, Smith AM, Wallace IM, Suresh S, Miranda M, et al. (2008) An integrated platform of genomic assays reveals small-molecule bioactivities. Nat Chem Biol 4: 498-506.